Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
暂无分享,去创建一个
J. Karbach | A. Kreutzman | V. Cerullo | S. Pesonen | T. Ranki | T. Viitala | E. Jäger | S. Feola | B. Martins | E. Ylösmäki | M. Fusciello | Leena Ylösmäki | P. Priha | Petra Ahokas | Hanne Cojoc | Arttu Uoti